Drug Shortage Report for CHOLOGRAFIN MEGLUMINE INJ. - LIQ IV

Last updated on 2018-12-20 History
Report ID 8489
Drug Identification Number 02228556
Brand name CHOLOGRAFIN MEGLUMINE INJ. - LIQ IV
Common or Proper name Cholografin
Company Name BRACCO IMAGING CANADA
Market Status CANCELLED POST MARKET
Active Ingredient(s) MEGLUMINE IODIPAMIDE
Strength(s) 52%
Dosage form(s) LIQUID
Route of administration INTRAVENOUS
Packaging size 10X20ml
ATC code V08AC
ATC description X-RAY CONTRAST MEDIA, IODINATED
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-05-01
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2018-12-20
Company comments This product is under review by the company's Marketing team as the demand has been very low over the last 7 years
Health Canada comments
Tier 3 Status No
Contact Address 11065 BOUL. L-H LAFONTAINE
VILLE D'ANJOU, QUEBEC
CANADA H1J 2Z4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2017-05-01 English Compare
v2 2017-05-01 English Compare
v3 2017-05-01 English Compare
v4 2017-05-01 English Compare
v5 2017-05-01 French Compare
v6 2017-05-02 English Compare
v7 2017-08-01 English Compare

Showing 1 to 7 of 7